Year |
Citation |
Score |
2020 |
Sigler A, He X, Bose M, Cristea A, Liu W, Nam PK, James D, Burton C, Shi H. Simultaneous Determination of Eight Urinary Metabolites by HPLC-MS/MS for Non-Invasive Assessment of Traumatic Brain Injury. Journal of the American Society For Mass Spectrometry. PMID 32700913 DOI: 10.1021/jasms.0c00181 |
0.76 |
|
2017 |
Burton C, Ma Y. Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges. Current Medicinal Chemistry. PMID 28914192 DOI: 10.2174/0929867324666170914102236 |
0.76 |
|
2016 |
Burton C, Shi H, Ma Y. Development of a high-performance liquid chromatography - Tandem mass spectrometry urinary pterinomics workflow. Analytica Chimica Acta. 927: 72-81. PMID 27237839 DOI: 10.1016/j.aca.2016.05.005 |
0.76 |
|
2016 |
Weng R, Shen S, Burton C, Yang L, Nie H, Tian Y, Bai Y, Liu H. Lipidomic profiling of tryptophan hydroxylase 2 knockout mice reveals novel lipid biomarkers associated with serotonin deficiency. Analytical and Bioanalytical Chemistry. PMID 26780709 DOI: 10.1007/s00216-015-9256-3 |
0.76 |
|
2016 |
Burton C, Shi H, Ma Y. Daily variation and effect of dietary folate on urinary pteridines Metabolomics. 12. DOI: 10.1007/s11306-016-1019-4 |
0.76 |
|
2015 |
Burton C, Dan Y, Donovan A, Liu K, Shi H, Ma Y, Bosnak CP. Urinary Metallomics as a Novel Biomarker Discovery Platform: Breast Cancer as a Case Study. Clinica Chimica Acta; International Journal of Clinical Chemistry. PMID 26585752 DOI: 10.1016/j.cca.2015.11.014 |
0.76 |
|
2015 |
Weng R, Shen S, Tian Y, Burton C, Xu X, Liu Y, Chang C, Bai Y, Liu H. Metabolomics Approach Reveals Integrated Metabolic Network Associated with Serotonin Deficiency. Scientific Reports. 5: 11864. PMID 26154191 DOI: 10.1038/srep11864 |
0.4 |
|
2015 |
Burton C, Weng R, Yang L, Bai Y, Liu H, Ma Y. High-throughput intracellular pteridinic profiling by liquid chromatography-quadrupole time-of-flight mass spectrometry. Analytica Chimica Acta. 853: 442-50. PMID 25467489 DOI: 10.1016/j.aca.2014.10.044 |
0.76 |
|
2015 |
Ma Y, Burton C, Shi H. A rebuttal to "A comment to 'Normalization of urinary pteridines by urine specific gravity for early cancer detection' [Clin. Chim. Acta 435 (2014) 42-47]". Clinica Chimica Acta; International Journal of Clinical Chemistry. 438: 415-7. PMID 25245674 DOI: 10.1016/j.cca.2014.08.044 |
0.76 |
|
2014 |
Burton C, Shi H, Ma Y. Normalization of urinary pteridines by urine specific gravity for early cancer detection. Clinica Chimica Acta; International Journal of Clinical Chemistry. 435: 42-7. PMID 24792383 DOI: 10.1016/j.cca.2014.04.022 |
0.76 |
|
2013 |
Burton C, Shi H, Ma Y. Simultaneous detection of six urinary pteridines and creatinine by high-performance liquid chromatography-tandem mass spectrometry for clinical breast cancer detection. Analytical Chemistry. 85: 11137-45. PMID 24138137 DOI: 10.1021/ac403124a |
0.76 |
|
2013 |
Ma Y, Burton C. Pteridine detection in urine: the future of cancer diagnostics? Biomarkers in Medicine. 7: 679-81. PMID 24044558 DOI: 10.2217/bmm.13.88 |
0.76 |
|
2013 |
Burton C, Gamagedara S, Ma Y. Partial enzymatic elimination and quantification of sarcosine from alanine using liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 405: 3153-8. PMID 23354581 DOI: 10.1007/s00216-013-6740-5 |
0.76 |
|
Show low-probability matches. |